NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

Mise à jour : Il y a 4 ans
Référence : NCT00213577

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750 versus 500 units) of the Dysport type A botulinic toxin for patient suffering from neurogenic urinary incontinence by an overactive bladder and the failure of anticholinergic drugs.


Critère d'inclusion

  • Overactive Bladder

Liens